Coronary heart disease mortality amongst non-insulin-dependent diabetic subjects in Iceland: The independent effect of diabetes. The Reykjavik Study 17-year follow up

Journal of Internal Medicine

Volumn 244, Issue 4, 1998, Pages 309-316

  Vilbergsson, S ^a,b   Sigurdsson, G ^b,c   Sigvaldason, H ^a   Sigfusson, N ^a  

^a ICELANDIC HEART ASSOCIATION   (Iceland)

^b UNIVERSITY OF ICELAND   (Iceland)

^c Reykjavik City Hospital   (Iceland)

Author keywords

Coronary heart disease; Epidemiology; Iceland; Mortality and non insulin dependent (Type 2) diabetes mellitus

Indexed keywords

ADULT; AGED; ARTICLE; CAUSE OF DEATH; CORONARY RISK; FEMALE; FOLLOW UP; HUMAN; ICELAND; ISCHEMIC HEART DISEASE; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADULT; AGE DISTRIBUTION; AGED; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; GLUCOSE TOLERANCE TEST; HUMANS; ICELAND; LIFE EXPECTANCY; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK; RISK FACTORS; SURVIVAL RATE;

EID: 0031695210     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1998.00368.x     Document Type: Article

References (31)

1. Pranzram C. Mortality and survival in type 2 (non-insulin-dependent diabetes mellitus). Diabetologia 1987; 30: 123-31.
2. Pyorala K, Laakso M, Uusitupa M. Diabetes and atherosclerosis: an epidemiological view. Diabetes Metab Rev 1987; 3: 463-524.
3. Waugh NR, Dallas JH, Jung RT, Newton RW. Mortality in a cohort of diabetic patients: causes and relative risks. Diabetologia 1989; 32: 103-4.
4. Kannel WB, McGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham Study. Diabetes Care 1979; 2: 120-6.
5. Pinsky JL, Branch LG, Jette AM, Haynes SG, Feinleib M, Coroni-Huntley JC et al. Framingham Disability Study: relationship of disability to cardiovascular risk factors among persons free of diagnosed cardiovascular disease. Am J Epidemiol 1985; 122: 644-56.
6. Butler WJ, Ostrander LD Jr, Carman WJ, Lamphiear DE. Mortality from coronary heart disease in the Tecumseh Study: long-term effect of diabetes mellitus, glucose tolerance and other risk factors. Am J Epidemiol 1985; 121: 541-7.
7. Feskens EJM, Kromhout D. Glucose tolerance and the risk of cardiovascular disease: the Zutphen Study. J Clin Epidemiol 1992; 45: 1327-34.
8. Nathan DM, Meigs J, Singer DE. The epidemiology of cardiovascular disease in type 2 diabetes mellitus: how sweet it is ... or is it? Lancet 1997; 350: 4-9.
9. Donahue RP, Orchard TJ. Diabetes mellitus and macrovascular complications. An epidemiological perspective. Diabetes Care 1992; 15: 1141-55.
10. Uusitupa MIJ, Niskanen LK, Siitonen O, Vautilainen K, Pyorala K. Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia 1993; 36: 1175-84.
11. Keys A. Coronary heart disease in seven countries. Circulation 1970; 41/42 (Suppl. I): 1-211.
12. Owerbach D, Johansen K, Billesbolle P, Poulsen S, Schroll M, Nerup J. Possible associations between DNA sequences flanking the insulin gene and atherosclerosis. Lancet 1982; 2: 1291-3.
13. Sigurdsson E, Thorgeirsson G, Sigvaldason H, Sigfusson N. Prevalence of coronary heart disease in Icelandic men 1968-86. The Reykjavik Study. Eur Heart J 1993; 14: 584-91.
14. Vilbergsson S, Sigurdsson G, Sigvaldason H, Hreidarson ÁB, Sigfusson N. Prevalence and incidence of NIDDM in Iceland: evidence for stable incidence among males and females 1967-91: The Reykjavik Study. Diabetes Med 1997; 14: 491-8.
15. WHO Study Group on Diabetes Mellitus. World Health Organization Tech Rep Ser 727. WHO, Geneva, 1985.
16. Anonymous. Prevalence of small vessel and large vessel disease in diabetic patients from 14 centres. The World Health Organisation Multinational Study of Vascular Disease in Diabetes. Diabetes Drafting Group. Diabetologia 1985; 28: 615-40.
17. Gebski V, Leung O, McNeil D, Lunn D. SPIDA User's Manual, Version 6, Statistical Computing Lab., Macquarie University, University of NSW Australia, 1992.
18. Eschwége E, Balkau B, Fontbonne A. The epidemiology of coronary heart disease in glucose-intolerant and diabetic subjects. J Intern Med 1994; 236: 5-11.
19. Kuusisto J, Mykkänen L, Pyörälä K, Laakso M. NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 1994; 45: 960-7.
20. de Grauw WJC, de Lisdonk EH, van den Hoogen HMJ, van Weel C. Cardiovascular morbidity and mortality in type 2 diabetic patients: a 22-year historical cohort study in Dutch general practice. Diabetes Med 1995; 12: 117-22.
21. Hanefeld M, Schmechel H, Schwanebeck U, Linder J. The DIS. Group, Predictors of coronary heart disease and death in NIDDM. The Diabetes Intervention Study experience. Diabetologia 1997; 40: 123-4.
22. Lundberg V, Stegmayr B, Asplund K, Eliasson M, Huhtasaari F. Diabetes as a risk factor for myocardial infarction: population and gender perspectives. J Int Med 1997; 241: 485-92.
23. Hadden DR, Patterson CC, Atkinson AB, Kennedy L, Bell PM, McCane DR et al. Macrovascular Disease and hyperglycaemia: 10-year survival analysis in type 2 diabetes mellitus: the Belfast Diet Study. Diabetic Med J 1997; 14: 663-72.
24. Laakso M, Rönnemaa T, Letho S, Puukka P, Kallio V, Pyorala K. Does NIDDM increase the risk for coronary heart disease similarly in both low-and high-risk populations? Diabetologia 1995; 38: 487-93.
25. Taskinen MR. Hyperlipidaemia in diabetes. Baillieres Clin Endocrinol Metab 1990; 4: 743-75.
26. Pyorala K, Pedersen TR, Kjekshus J, Faergeman Olson AG, Thorgeirsson G. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). Diabetes Care 1997; 20: 614-20.
27. Sigurdsson G, Nicoll A, Lewis B. The metabolism of low density lipoprotein in endogenous hypertriglyceridaemia. Europ J Clin Invest 1976; 6: 151-8.
28. Lehto S, Rönnemaa T, Haffner SM, Pyörälä K, Kallio V, Laakso M. Dyslipidaemia and hyperglycaemia predict coronary heart disease events in middle-aged patients with NIDDM. Diabetes 1997; 46: 1354-9.
29. Sigfusson N, Sigvaldason H, Steingrimsdottir L, Gudmundsdottir II, Stefansdottir I, Thorsteinsson T et al. Decline in ischaemic heart disease in Iceland and change in risk factor level. BMJ 1991; 302: 1371-5.
30. Goodkin G. Mortality factors in diabetes. J Occup Med 1975; 17: 716-21.
31. Panzam G, Zabel-Langhenning R. Prognosis of diabetes mellitus in a geographically defined population. Diabetologia 1981; 20: 587-91.